Browse
AI Directory Open Source AI News 🏆 AI Challenge AI Statistics
Browse by profession
Accounting, Bookkeeping & TaxCompliance, Audit & GRCConstructionCustomer SupportData ScienceMedical All 38 professions →
Company
About Advertise Submit a tool Get the free Medical AI guide
Overview Before & After Try It Reviews Integrations Why This Tool FAQ Pricing Top 10 Get Alerts News

Translate complex biological data—from histology to genomics—into clinically actionable insights for patient stratification and treatment planning.

Leverage a foundation model trusted by 16 of the top 20 pharma companies to predict treatment response and discover novel biomarkers.

Best forPredicting treatment response from multimodal data
DifferentiatorFoundation model integrating histology, genomics, and spatial transcriptomics.
ProofTrusted by 16/20 top pharma companies; #1 on PathBench benchmark.
Explore Bioptimus
Pricing on request
8.4 Zekai
Research-Grade Biological Intelligence
AI for Doctors & Medical
Ease of Use
7.2
Accuracy
9.4
Value
8.0
Time Saving
8.8
1M+Users
8.4/10Zekai Score
Biomarker DiscoveryPredictive AnalyticsClinical Trial OptimizationMultimodal Data FusionPathology AI
🏷 Is this your tool? Claim this listing →
Hand-scored by Zekai

Top AI for Doctors & Medical picks

See all 72 AI for Doctors & Medical tools →
⚡ Quick answer

For physicians in clinical research, Bioptimus is the best AI for decoding complex biology to improve trial design and patient stratification. It integrates multimodal data—like histology, genomics, and clinical records—to discover novel biomarkers and predict treatment response. Its models are ranked #1 on industry benchmarks and are trusted by 16 of the top 20 pharma companies, proving its capability in high-stakes research environments.

CategoryMedical Research & Diagnostics
Best ForPredicting treatment response from multimodal data
Price FromOn request
FreeNo
DifferentiatorFoundation model integrating histology, genomics, and spatial transcriptomics.
ProofTrusted by 16/20 top pharma companies; #1 on PathBench benchmark.
Rating4.2/5
📖 About Bioptimus
Real Impact

Before & After

❌ Before

Struggling to stratify patients with standard biomarkers

Low trial success probability
✅ After

Discovering novel, multimodal signatures to predict response

Increased asset rNPV
Prompt Templates

Try it with these prompts

Copy any prompt and paste it directly into the tool.

Predict Drug Targets from Histology Slides

Analyze routine histology slides to predict the spatial distribution of ADC drug targets, immune microenvironment, and stromal architecture. Upload your H&E slides to identify potential drug targets without needing new a…

Identify Patient Subsets for Drug Efficacy

Score archival cohorts across disease, stage, and mechanism of action to identify patient subsets that will respond to your drug. Use existing clinical trial data and H&E slides to find where your drug has the best chanc…

Discover Biomarkers for Treatment Response

Analyze multimodal data including histology, spatial transcriptomics, and genomics to discover biomarker signatures distinguishing responders from non-responders. Integrate signals from a single pipeline to find clinical…

Social Proof

Trusted by 1M+

1M+ professionals using this tool
Ease of Use
7.2
Accuracy
9.4
Value
8.0
Time Saving
8.8

"Bioptimus is fundamentally changing how we approach indication expansion. The ability to screen our archived trial data for new patient subsets is accelerating our pipeline significantly."

David C., Head of Translational Medicine · May 2026

"The performance of H-Optimus on our histology slides is unparalleled. We're extracting spatial biology insights that were previously impossible without dedicated, expensive assays."

Maria R., Director of Pathology AI · April 2026

"The insights are powerful, but the integration process is not trivial. It requires dedicated bioinformatics support to prepare the data and manage the pipeline effectively. Not a plug-and-play solution."

Kenji T., Principal Investigator · March 2026

"We identified a predictive biomarker signature in an early-phase cohort that we had completely missed with standard analysis. This has reshaped our entire Phase II strategy."

Sophie L., Clinical Research Scientist · May 2026
1M+ professionals are already using this tool.
See Plans & Pricing →
Connects With

Works with your existing stack

Histology Slides (H&E) Sequencing Data Genomics Data Spatial Transcriptomics Data Clinical Records
Setup complexity: Expert
Bioptimus offers a biological foundation model for physicians and researchers to analyze multimodal data like histology, genomics, and clinical records. It deciphers complex patterns to predict treatment response, discover biomarkers, and stratify patients, turning archival data into a predictive engine for clinical trials and diagnostics.
Comparison

How it compares

Bioptimus vs. Owkin: Both are leaders in using AI for drug discovery and diagnostics. Owkin focuses heavily on federated learning to train models on decentralized data from hospitals without moving it, emphasizing patient privacy and data access. Choose Owkin if your primary challenge is accessing and training on sensitive, siloed hospital data. Bioptimus, by contrast, emphasizes its powerful, multimodal foundation models (like M-Optimus) that integrate diverse data types—from histology to genomics—into a single, unified 'world model of biology'. Choose Bioptimus when your goal is to uncover the deepest biological insights by fusing these different data modalities, especially if you have complex data ready for deep analysis.

The decision

Is it worth it?

Return on investment
By identifying non-responders before a Phase III trial, Bioptimus can save millions in development costs and increase an asset's risk-adjusted net present value (rNPV).
Built for
Physician-scientists, clinical researchers, pathologists, and oncologists working in academic medical centers, research institutions, and pharmaceutical companies.
Effort to adopt
Expert
Compliance
Compliance posture not publicly documented — verify with vendor.
Who It's For

Why Doctors & Medical choose this tool

🎯
Built for
Best for clinical researchers and pathologists aiming to uncover novel biomarkers and predict patient treatment response from multimodal biological data.
In-Depth Overview
For physicians involved in clinical research and diagnostics, Bioptimus provides a direct path to deeper biological understanding without requiring new assays. Its models, like M-Optimus, are designed to learn jointly from histology, spatial transcriptomics, and genomics. This allows you to predict the spatial distribution of drug targets or immune microenvironments directly from routine H&E slides. The platform has been validated by its #1 ranking on industry benchmarks like PathBench and is used by over 1,000 institutions, including 16 of the top 20 pharmaceutical companies. By integrating signals that standard workups miss, Bioptimus helps you discover multimodal biomarker signatures that distinguish responders from non-responders, even in small early-phase trials. This capability directly supports indication expansion for existing drugs and improves the design of future clinical trials by increasing the probability of success before Phase III.

Key Use Cases

🔬
Identify Responders in an Early-Phase Trial
Clinical Researcher
Analyze histology and genomic data from a small cohort to find a multimodal biomarker signature that separates drug responders from non-responders.
Improved patient stratification
🥼
Enhance Diagnostic Insights from H&E Slides
Pathologist
Use the H-Optimus model to predict the immune microenvironment and stromal architecture from routine histology slides, adding a layer of spatial biology insight.
Actionable data from existing slides
💊
Find New Indications for an Existing Drug
Oncologist (Pharma R&D)
Screen archival cohorts from past trials to identify patient subsets in different diseases whose spatial biology matches the drug's mechanism of action.
Accelerated indication expansion
✓ Pros
Integrates multiple data types (histology, genomics) for a holistic view.
Trusted and used by top-tier pharmaceutical companies and research institutions.
Proven performance, ranked #1 on independent industry benchmarks.
Enables biomarker discovery from existing archival data, no new assays required.
Aims to increase clinical trial success rates by improving patient stratification.
· Cons
Pricing and access are not transparent; requires direct contact and partnership.
Primarily designed for large institutions and research teams, not individual clinicians.
Requires significant data infrastructure and expertise to leverage fully.
Focus is on research and development, not routine point-of-care diagnostics yet.
⚡ Editorial Verdict

Bioptimus is a powerful, research-grade platform for decoding complex biology. Its ability to integrate histology, genomics, and other data is a significant leap for precision medicine. The primary trade-off is its institutional focus; it's not a tool for individual practitioners but a large-scale engine for research teams and pharma.

Questions & Answers

Frequently asked questions

How does Bioptimus help in predicting patient response to treatment?

+
By integrating signals across histology, genomics, and clinical records, Bioptimus models discover complex biomarker signatures that distinguish responders from non-responders, even when standard biomarkers are the same.

Can I use Bioptimus with my existing patient data?

+
Yes, the platform is designed to get more from your existing data. You can use archived histology slides, sequencing data, and clinical records to power its analyses for biomarker discovery and patient stratification.

Is Bioptimus suitable for a solo physician's practice?

+
Bioptimus is built for large-scale research and institutional use, such as in pharmaceutical companies and academic medical centers. It is not designed for individual practitioners or small private practices.

What kind of data does Bioptimus integrate?

+
The models are built to jointly learn from many data types and scales, including histology (H&E slides), spatial transcriptomics, and genomics, along with clinical records.

Is Bioptimus available for use by medical professionals in Canada?

+
Yes, Bioptimus is available to institutions worldwide. Its STELA data initiative spans geographies, and it partners with global pharmaceutical companies and research centers, including those in Canada.

Is Bioptimus available for use in the UK and Europe?

+
Yes, Bioptimus operates globally and partners with institutions worldwide, including those in the UK and Europe. The team includes experts from top European institutions like Cambridge, ETH Zürich, and Helmholtz.

Last reviewed:

Plans & Pricing

Start today

Enterprise
Pricing on request
Tailored for teams and large organisations.
Contact Sales

Prices and features are updated regularly but can change at any time — always confirm on the official website. Some links on this page are affiliate links.

See all 72 AI for Doctors & Medical tools →
Free guide

Take it with you

Getting Started with Multimodal AI in Clinical Research
  • **Understand Foundation Models:** Learn how large-scale models like M-Optimus go beyond single-data-type analysis.
  • **Identify Your Data Assets:** Catalogue your archived histology slides, sequencing data, and clinical records.
  • **Define Your Research Question:** Pinpoint your goal, whether it's biomarker discovery, patient stratification, or indication expansion.
  • **Leverage Archival Data:** See how to turn dormant data from past trials into a powerful screening engine.
  • **Predictive vs. Descriptive:** Shift from describing patient cohorts to predicting their response to treatment.
+4 more steps inside the guide
Send me the full guide

Get Bioptimus deal alerts

Be the first to know when Bioptimus drops a new discount, adds features, or changes pricing.

Exclusive Bioptimus discount codes
New feature announcements
Best alternative picks when pricing changes
Zero spam — unsubscribe anytime
🎉
You're subscribed!
We'll notify you when Bioptimus has a new deal.
AI Directory

About Bioptimus

Full Description

Bioptimus offers a biological foundation model for physicians and researchers to analyze multimodal data like histology, genomics, and clinical records. It deciphers complex patterns to predict treatment response, discover biomarkers, and stratify patients, turning archival data into a predictive engine for clinical trials and diagnostics.

Editorial Verdict

Bioptimus is a powerful, research-grade platform for decoding complex biology. Its ability to integrate histology, genomics, and other data is a significant leap for precision medicine. The primary trade-off is its institutional focus; it's not a tool for individual practitioners but a large-scale engine for research teams and pharma.

Last reviewed:
Disclaimer
Zekai is an independent AI tools directory. We are not affiliated with, endorsed by, or officially connected to Bioptimus unless clearly stated. All product names, logos, and brands are the property of their respective owners and are used for identification purposes only. The information on this page — including pricing, features, and availability — is general information, may have changed since our last review, and is not professional advice. Zekai Scores and verdicts are our editorial opinion. Some outbound links are affiliate links that may earn us a commission at no extra cost to you. Spotted outdated or incorrect information? Request a correction →
Previous Tool Ubenwa Next Tool Sword Health
All AI Tools A–Z →
Visit website ↗
Bioptimus8.4Try Bioptimus ↗Next tool →
Today's top 3 AI for Doctors & Medical tools →